Novasep offers complete downstream processing solutions for the production and separation of biopharmaceuticals originating from recombinant and non recombinant DNA, based on its world leading array of biochromatography and TFF (tangential flow filtration) technologies.
Moreover, with the recent acquisition of Henogen, Novasep now offers complete contract manufacturing services, from the gene to the vial, for the production of biopharmaceuticals using a broad range of expression technologies, including microbial, mammalian and insect cells as well as viral vectors.
Visit the Henogen web site for more information about our global biomanufacturing capabilities.
To learn more about our biopharmaceutical solutions:
Contact us for any biopharmaceutical purification request.